Murungi LM[Author] - Search Results

Year	Number of Results
2010	1
2012	1
2013	2
2015	2
2016	3
2017	3
2018	1
2019	1
2021	1

1

Serological Profiling for Malaria Surveillance Using a Standard ELISA Protocol.

Murungi LM, Kimathi RK, Tuju J, Kamuyu G, Osier FHA. Murungi LM, et al. Methods Mol Biol. 2019;2013:83-90. doi: 10.1007/978-1-4939-9550-9_6. Methods Mol Biol. 2019. PMID: 31267495

2

Vaccine candidate discovery for the next generation of malaria vaccines.

Tuju J, Kamuyu G, Murungi LM, Osier FHA. Tuju J, et al. Among authors: murungi lm. Immunology. 2017 Oct;152(2):195-206. doi: 10.1111/imm.12780. Epub 2017 Jul 24. Immunology. 2017. PMID: 28646586 Free PMC article. Review.

3

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.

Kamuyu G, Tuju J, Kimathi R, Mwai K, Mburu J, Kibinge N, Chong Kwan M, Hawkings S, Yaa R, Chepsat E, Njunge JM, Chege T, Guleid F, Rosenkranz M, Kariuki CK, Frank R, Kinyanjui SM, Murungi LM, Bejon P, Färnert A, Tetteh KKA, Beeson JG, Conway DJ, Marsh K, Rayner JC, Osier FHA. Kamuyu G, et al. Among authors: murungi lm. Front Immunol. 2018 Dec 11;9:2866. doi: 10.3389/fimmu.2018.02866. eCollection 2018. Front Immunol. 2018. PMID: 30619257 Free PMC article.

4

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labbé GM, Alanine DG, Siani L, Di Marco S, Roberts R, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, McCarthy JS, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ. Payne RO, et al. Among authors: murungi lm. JCI Insight. 2017 Nov 2;2(21):e96381. doi: 10.1172/jci.insight.96381. JCI Insight. 2017. PMID: 29093263 Free PMC article. Clinical Trial.

5

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper SJ, Osier FHA. Murungi LM, et al. Infect Immun. 2016 Mar 24;84(4):950-963. doi: 10.1128/IAI.01120-15. Print 2016 Apr. Infect Immun. 2016. PMID: 26787721 Free PMC article.

6

Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria.

Llewellyn D, Miura K, Fay MP, Williams AR, Murungi LM, Shi J, Hodgson SH, Douglas AD, Osier FH, Fairhurst RM, Diakite M, Pleass RJ, Long CA, Draper SJ. Llewellyn D, et al. Among authors: murungi lm. Sci Rep. 2015 Sep 16;5:14081. doi: 10.1038/srep14081. Sci Rep. 2015. PMID: 26373337 Free PMC article.

7

Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.

Murungi LM, Sondén K, Odera D, Oduor LB, Guleid F, Nkumama IN, Otiende M, Kangoye DT, Fegan G, Färnert A, Marsh K, Osier FH. Murungi LM, et al. Int J Parasitol. 2017 Feb;47(2-3):153-162. doi: 10.1016/j.ijpara.2016.09.005. Epub 2016 Nov 24. Int J Parasitol. 2017. PMID: 27890694 Free PMC article.

8

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.

Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, Marsh K, Osier FH. Murungi LM, et al. Vaccine. 2013 Aug 20;31(37):3936-42. doi: 10.1016/j.vaccine.2013.06.042. Epub 2013 Jun 22. Vaccine. 2013. PMID: 23800539 Free PMC article.

9

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.

Williams AR, Douglas AD, Miura K, Illingworth JJ, Choudhary P, Murungi LM, Furze JM, Diouf A, Miotto O, Crosnier C, Wright GJ, Kwiatkowski DP, Fairhurst RM, Long CA, Draper SJ. Williams AR, et al. Among authors: murungi lm. PLoS Pathog. 2012;8(11):e1002991. doi: 10.1371/journal.ppat.1002991. Epub 2012 Nov 8. PLoS Pathog. 2012. PMID: 23144611 Free PMC article.

10

Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.

Kangoye DT, Mensah VA, Murungi LM, Nkumama I, Nebie I, Marsh K, Cisse B, Bejon P, Osier FH, Sirima SB; MVVC Infant Immunology Study Group. Kangoye DT, et al. Among authors: murungi lm. Vaccine. 2016 Jan 2;34(1):160-6. doi: 10.1016/j.vaccine.2015.10.058. Epub 2015 Nov 11. Vaccine. 2016. PMID: 26541134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results